This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Agilysys (AGYS) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Agilysys (AGYS) delivered earnings and revenue surprises of 33.33% and 6.06%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Iridex (IRIX) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Iridex (IRIX) delivered earnings and revenue surprises of 6.25% and 0.10%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Cambium (CMBM) Q1 Earnings Surpass Estimates
by Zacks Equity Research
Cambium (CMBM) delivered earnings and revenue surprises of 120% and 0.72%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
NCR (NCR) Misses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
NCR (NCR) delivered earnings and revenue surprises of -48.44% and 3.05%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Agilysys (AGYS) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Agilysys (AGYS) delivered earnings and revenue surprises of 46.15% and 5.37%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Agilysys (AGYS) Q2 Earnings Beat Estimates
by Zacks Equity Research
Agilysys (AGYS) delivered earnings and revenue surprises of 5.88% and -5.74%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Bear of the Day: International Business Machines (IBM)
by Jeremy Mullin
Big Blue disappoints again.
Earnings Preview: Agilysys (AGYS) Q2 Earnings Expected to Decline
by Zacks Equity Research
Agilysys (AGYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Agilysys (AGYS) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Agilysys (AGYS) delivered earnings and revenue surprises of 40.00% and 8.47%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Agilysys (AGYS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Agilysys (AGYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Agilysys (AGYS) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Agilysys (AGYS) delivered earnings and revenue surprises of 35.29% and 1.59%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
USA Technologies (USAT) Catches Eye: Stock Jumps 6.1%
by Zacks Equity Research
USA Technologies (USAT) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Agilysys (AGYS) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Agilysys (AGYS) delivered earnings and revenue surprises of 190.00% and 0.47%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Agilysys (AGYS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Agilysys (AGYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Top Stocks to Tap Computer - Integrated Systems Industry
by Vasundhara Sawalka
Despite bearing the brunt of coronavirus-led supply constraints, the Computer - Integrated Systems industry players like IBM, HPE, NCR and AGYS are benefiting from increased demand for integrated solutions and growing adoption of the multi-cloud model.
Agilysys (AGYS) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Agilysys (AGYS) delivered earnings and revenue surprises of 900.00% and 13.77%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Will Agilysys (AGYS) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Agilysys (AGYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Agilysys (AGYS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Agilysys (AGYS) closed at $17.49 in the latest trading session, marking a +0.75% move from the prior day.
Agilysys (AGYS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Agilysys (AGYS) closed the most recent trading day at $23.89, moving +0.89% from the previous trading session.
Agilysys (AGYS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Agilysys (AGYS) closed at $19.23, marking a -1.03% move from the previous day.
Agilysys (AGYS) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Agilysys (AGYS) delivered earnings and revenue surprises of -866.67% and -1.54%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Will Agilysys (AGYS) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Agilysys (AGYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Agilysys (AGYS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Agilysys (AGYS) closed the most recent trading day at $18.23, moving -0.33% from the previous trading session.
Agilysys, Manpower, Eli Lilly and Company, Innoviva and AbbVie highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Agilysys, Manpower, Eli Lilly and Company, Innoviva and AbbVie highlighted as Zacks Bull and Bear of the Day
Bull Of The Day: Agilysys (AGYS)
by Brian Bolan
If you are looking for a stock that has not seen that much of a bounce in the early days of the recovery be sure to read this.